Open AccessMajor Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
Author(s) -
Anjum S. Kaka,
Roderick MacDonald,
Eric J. Linskens,
Lisa Langsetmo,
Kathryn Vela,
Wei Duan-Porter,
Timothy J Wilt
Publication year - 2022
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m21-4784
Subject(s) - medicine , randomized controlled trial , data extraction , medline , covid-19 , meta analysis , cochrane library , grading (engineering) , placebo , systematic review , emergency medicine , alternative medicine , civil engineering , disease , pathology , political science , infectious disease (medical specialty) , law , engineering
Remdesivir is approved for the treatment of adults hospitalized with COVID-19.